Food and Drug Administration Commissioner Marty Makary said approving drugs for human consumption is moving at a “record” pace.

Makary confirmed that the FDA’s review process will not slow down despite layoffs at the Department of Health and Human Services. During a Wednesday appearance on CNBC’s Squawk Box, he assured the public that the administration is approving products “on target” and could set a record.

Recommended Stories

FDA requires overdose risk on opioid prescription labels

FDA warns against ‘young blood’ transfusions

Dr. Oz and FDA chief say biosimilar drug reform will lower prices